Adenovirus vector-mediated delivery of the CRISPR-CasRx system enables gene knockdown with suppressed collateral activity
Yuki OSAKADA, Sota Kidawara, Eiko Sakai, Akira Asayama et autres
gene knockdown without evident side effects from collateral activity or Cas13 expression itself in liver.
jp (code pays fourni par la source)